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ABSTRACT
INTRODUCTION Water-pipe (WP) smoking is the most common method of tobacco 
consumption in the Middle-East and is rapidly spreading on a global scale. 
Although, water-pipe smoking is linked to various diseases, such as emphysema 
and various types of cancers, its effect on testosterone levels has yet to be 
investigated. This study explores the effect of water-pipe smoking on serum 
testosterone levels in males in Qatar.
METHODS In this cross-sectional sample within a cohort study, we retrieved data for 
a total of 1000 male volunteers from the Qatar BioBank (QBB) project. A self-
reported questionnaire was used to determine the water-pipe smoking status of 
participants. Moreover, participants were stratified based on the frequency of 
smoking. Total testosterone and sex hormone binding globulin (SHBG) were 
measured clinically, whereas free testosterone and bioavailable testosterone were 
calculated using Vermeulen’s equation. Hormone values of 541 males (277 water-
pipe smokers and 264 non-smokers) were compared using multiple regression 
analysis based on water-pipe smoking status after adjusting for confounding 
factors.
RESULTS No statistically significant difference was observed between WP smokers 
and non-water-pipe smokers in the likelihood of having lower or higher total 
testosterone, after adjustment for confounding factors. Similar results were 
found in free testosterone, bioavailable testosterone, and sex hormone binding 
globulin (all p>0.05). When compared with the reference group, both light 
and heavy water-pipe smokers had a similar likelihood of circulating low total 
testosterone levels (OR=0.83, 95% CI: 0.46–1.49; and OR=0.80, 95% CI: 0.43–
1.49; respectively).
CONCLUSIONS Our results reveal, for the first time, that there is no significant change 
in total testosterone, free testosterone, bioavailable testosterone and sex hormone 
binding globulin in waterpipe smokers compared to non-water-pipe smokers. 
Therefore, we believe that further studies are needed to confirm the effect of 
water-pipe smoking on testosterone in different populations.
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INTRODUCTION
Tobacco smoking is considered responsible for 
numerous serious human diseases, according to the 
World Health Organization (WHO), making it one of 
the main causes of preventable illness and mortality 
worldwide. Tobacco smoking is consumed in various 
forms encompassing cigarette, cigar, e-cigarette, and 
water-pipe (WP). Today, WP smoking is the most 
widespread method of tobacco consumption in the 
Middle-East and is rapidly spreading globally as a form 
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of social conduct1. WP and cigarettes both contain 
similar toxins such as nicotine, carbon monoxide and 
polycyclic aromatic hydrocarbons (PAH)2; hence, it 
is a misconception that WP smoking is less harmful 
than cigarette smoking. More specifically, WP 
smoke contains significantly more carbon monoxide, 
equivalent to that from 10 cigarettes per day3. In 
addition to these toxins, WP smoking also exposes 
smokers to fine charcoal particles, resin particles, 
flavourings, sweeteners, and added perfumes4.
Furthermore, recent studies clearly show the 
harmful effects of WP smoking on human health, 
which include chronic bronchitis, emphysema, 
coronary artery disease, lung, gastric and esophageal 
cancers, and osteoporosis along with significant 
effects on embryogenesis5,6. Meanwhile, earlier studies 
assessed the relationship between cigarette smoking 
and testosterone levels in men arriving at controversial 
conclusions, with undetermined mechanisms7,8.
While there is no investigation concerning the effect 
of WP smoking on the serum levels of testosterone 
in men, a study on male mice showed that chronic 
WP smoke exposure has adverse effects on the male 
reproductive system including testosterone levels9. 
The mechanism by which WP smoking could affect 
testosterone levels is under research9. Also, changes in 
testosterone levels have been linked to many disorders 
such as erectile dysfunction, cardiovascular diseases, 
Type-2 diabetes mellitus (DM), metabolic syndrome, 
and obesity10. Therefore, evaluating the outcome of 
WP smoking on testosterone levels is essential to 
identify and/or explain known WP smoking-associated 
pathologies. This study aims to explore the association 
between WP smoke and serum levels of total 
testosterone (TT), free testosterone (FT), bioavailable 
testosterone (BioT) and sex hormone binding globulin 
(SHBG) among men in Qatar. Thus, this investigation 
addresses, for the first time, an important gap in the 
outcome of WP smoking on testosterone levels. 
METHODS 
Study design and population
Our study was conducted using data from the Qatar 
BioBank (QBB) project (https://www.qatarbiobank.
org.qa). In brief, QBB is a population-based 
longitudinal cohort that recruits adults who are 
nationals and long-term (>15 years) residents of Qatar 
between 18 and 89 years of age, and follows them up 
to record their health status. Recruitment started in 
December 2012 and collected information of 12000 
participants, and continues to date. Participation was 
voluntary, and bookings were made through the 
website or by phone calls. After obtaining a written 
informed consent, all participants answered a self-
administered questionnaire. Also, anthropometrics 
and body composition were measured, followed by a 
collection of blood and urine samples.
Our cross-sectional sampling within the cohort 
study11 collected a random sample of 1000 males from 
the 5500 adult males who participated in QBB until 
December 2017 and measured the association between 
WP smoking and testosterone level. Up to the time 
the study was conducted, the study group had been 
exposed to WP smoking for a mean duration of 13 
years. Exclusion criteria for our study included history 
of DM, liver cirrhosis, psychiatric disorders, neoplastic 
conditions, pelvic surgeries, obesity stage II or III, body 
mass index (BMI > 35), participants who smoked WP 
before but were no longer smokers at the time of the 
study, and participants with missing data of TT, SHBG, 
or WP smoking status. The final sample size was 541 
participants for whom we could detect a difference 
of 1.5 units in means or 10% in proportion between 
exposed and non-exposed groups with a power of 80% 
and an alpha level of 0.05. This study was approved by 
the QBB institutional review board (IRB) and Qatar 
University IRB, where the study was conducted.
Confounding factors
Factors that are associated with testosterone levels 
were investigated as potential confounding factors. 
To assess which of these factors can be considered 
true confounding factors and should be included 
in the analysis, a directed acyclic graph (DAG)12 
was developed as illustrated in Figure 1. The DAG 
included the exposure, outcome and other factors 
that have a relationship with the outcome, such as 
age, concurrent cigarette smoking, BMI, triglycerides, 
HbA1c, level of physical activity, and prolactin level. 
Waist-hip ratio was not included as it has a linear 
relationship with BMI. The DAG revealed that only 
age and cigarette smoking status are confounding 
factors that are associated with both exposure and 
outcome, thus, these have been adjusted for in the 
analysis (Figure 1). Alcohol consumption was not 
included as it is exceedingly rare in Qatar. 
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WP smoking status
Part ic ipants  answered a sel f-administered 
questionnaire about their WP smoking status, the 
frequency of smoking, and duration of smoking. Men 
who smoked at least once in the last month were 
considered  smokers, men who had never smoked 
throughout their life were considered non-smokers, 
and men who stopped smoking were excluded from 
the analysis to avoid misclassification bias. Smokers 
were stratified into heavy and light smokers; heavy 
smokers were classified as men who smoked more 
than once per week, light smokers were classified 
as men who smoked three times or less in the last 
month. Heavy and light smokers had smoked for 11.9 
and 13.7 years, respectively, which were considered 
similar (p=0.084). Therefore, smoking duration was 
not considered when smokers were stratified.  
Anthropometrics and laboratory measurements
Anthropometrics were measured by a trained nurse. 
TANITA BC-418 MA instrument was used to measure 
participants’ weight (Kg) and height (m). BMI was 
calculated and treated as a continuous variable.
Physical activity data were collected by a 
questionnaire. The patients were asked about the 
total number of days and the average time spent per 
day in various activities, used to calculate the total 
metabolic equivalence13. Cigarette smoking status was 
self-reported by the participants and then categorised 
to non-smokers, light smokers, and heavy smokers 
based on the frequency and number of cigarettes 
smoked per day.
Blood samples were collected from patients in the 
morning (7:30–13:30) and immediately transferred 
frozen (at -80°C) to Hamad Medical Corporation’s 
(HMC) chemistry laboratory, Doha, Qatar. The 
samples were analysed within 2 hours following their 
standard operating procedures. TT was measured 
by the Abbott testosterone method following the 
manufacturer’s specifications. SHBG was measured 
by immunometric assay with fluorescence detection 
on the DPC Immulite 2000 analyzer following the 
manufacturer’s protocol. FT and BioT were calculated 
using Vermeulen’s equation14. Triglycerides were 
measured by GPO-PAP. HbA1c was measured by 
turbidimetric inhibition immunoassay (TINIA).
Figure 1. A directed acyclic graph that shows the relationship between testosterone levels as a dependent 
variable, and WPS (water-pipe smoking) as the independent variable in the presence of several factors which 
are age, cigarette smoking, triglycerides, HbA1c, BMI, Prolactin, and physical activity. The figure shows that 
only age and cigarette smoking are confounding factors
Testosterone
Triglycerides
BMI
Cigarettes
WPS
Physical Activity
HbA1c
Outcome Exposure Co-variate Confounding Factor
Prolactin
Age
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Statistical analysis
Normal distribution was assessed by Shapiro-Wilk 
test and histograms. Means of normally distributed 
data were compared using t-test while Mann Whitney 
U-test was used for non-normally distributed data. 
Categorical variables were compared using chi-
squared test. Hormone levels were categorised into 
tertiles rather than clinical cutoffs as they do not apply 
to our population15.  To test whether missing values 
were missing completely at random (MCAR), Little’s 
MCAR test with expectation maximisation algorithm 
was conducted. Hormones categories were included 
as the dependent variables in a multiple regression 
analysis to test the relationship with WP smoking level 
(independent variable) after adjustment for age and 
cigarette smoking. The lower and higher tertiles of 
hormone levels were compared with the middle tertile 
to test whether WP smoking increases or decreases 
these hormones. Odds ratios (OR) and associated 95% 
confidence intervals (CI) were obtained. Statistical 
Package for Social Sciences (SPSS) 64-bit version 23 
was used to carry out the previous tests. All tests were 
two-tailed, and results were considered statistically 
significant if p-values were less than 0.05.
RESULTS
A total of 1000 participant were randomly selected 
from the 5500 males who attended the QBB project. 
Of these, 388 participants were excluded for not 
meeting the eligibility criteria, and 71 were excluded 
for missing values. Little’s MCAR test showed that 
missing values were completely at random (p=0.734). 
The analyses were conducted on the remaining 541 
participants; 277 subjects (51%) were WP smokers 
and 264 (49%) non-WP smokers (Figure 2). 
The characteristics of the sample population by 
WP smoking status are defined by mean ± SD, as 
depicted in Table 1. Of the eligible participants, 96% 
were Qatari males. Thus, the impact of ethnicity is 
insignificant. Participants in our sample were in the 
age range 19–80 years with mean age among non-
smokers higher than WP smokers (39.0±11.4 and 
34.2±8.6, respectively; p<0.001). The mean duration 
of WP smoking status was previously addressed, 
and no significance was detected in light smokers 
compared to heavy smokers (p=0.084). Moreover, 
the mean±SD for TT was 19.4±7.7 nmol/L, for FT 
0.4±0.2 nmol/L, and for BioT 9.9±3.8 nmol/L,  all 
significantly higher in WP smokers than in non-WP 
smokers (p=0.01); nevertheless, these results were not 
adjusted for other confounding factors, as mentioned 
Figure 2. A flowchart that shows the study population 
and the final sample size (QBB: Qatar BioBank, WP: 
water-pipe)
Excluded females
Randomly selected
Excluded
• Diabetes mellitus = 121
• Pelvic surgery = 24
• Body mass index ≥ 35 = 91
• Stopped smoking = 152
Missing data
• Sex hormone-binding globulin = 32
• Testosterone = 4
• WP smoking not reported = 35
12.000 QBB participants
5.500 Males
Total sample size
n= 1000
Sample size
n= 612
Final sample size
n= 541
WP smokers
n= 277
Non-WP smokers
n= 264
Table 1.  Baseline characteristics of 541 subjects 
grouped by WP smoking status 
WPS
n=277
NS
n=264 p
Age (years) 34.2±8.6 38.9±11.4 <0.001
BMI (kg/m2) 27.0±3.9 27.2±3.9 0.71
Physical activity (mL2/kg/min) 33.0±79.0 26.7±53.2 0.90
Cigarette smoking status
Non-smokers 98 (35) 246 (93)
<0.001Light-smokers 71 (26) 2 (1)
Heavy-smokers 108 (39) 16 (6)
HBA1c (%) 5.3±0.6 5.4±0.5 0.008
Triglycerides (mmol/L) 1.5±1.0 1.6±1.1 0.51
TT (nmol/L) 19.4±7.7 17.9±6.8 0.01
FT (nmol/L) 0.4±0.2 0.3±0.1 0.01
BioT (nmol/L) 9.9±3.8 9.1±3.1 0.01
SHBG (nmol/L) 34.4±16.5 34.6±15.5 0.96
Data are expressed as mean±standard deviation or as number of subjects and 
percentage, n (%). The p-values were obtained by t-test or Mann-Whitney U-test. 
WPS: water-pipe smoking, NS: non-smoker, BMI: body mass index, TT: total 
testosterone, FT: free testosterone, BioT: bioavailable testosterone, SHBG: sex hormone 
binding globulin.
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in the Methods section. Also, HBA1c was found to 
be significantly higher in non-WP smokers compared 
to WP smokers (p=0.008).  On the other hand, no 
significant difference was detected in the mean values 
of BMI (p=0.71), SHBG (p=0.97), physical activity 
(p=0.89), and triglycerides (p=0.51) between WP 
smokers and non-WP smokers. WP smokers are 
more likely to smoke cigarettes compared to non-WP 
smokers (p<0.001).
Table 2 illustrates the association between WP 
smoking and testosterone levels while adjusting for 
age and number of cigarettes smoked. TT levels 
were stratified into tertiles; low (1.0–14.9), middle 
(15.0–20.6), and high (20.7–51.3) nmol/L. The 
middle tertile values for the rest of the hormones 
were defined as 0.314–0.413 nmol/L for FT, 7.9–
10.5 nmol/L for BioT and 26.4–37.9 nmol/L for 
SHBG. Our analysis showed that WP smoking neither 
increases nor decreases TT, FT, BioT, or SHBG, when 
adjusted for potential confounders. Compared with 
the reference group, both light and heavy WP smokers 
had a similar likelihood of circulating low TT levels 
(OR=0.83, 95% CI: 0.46–1.49; and OR=0.80, 95% 
CI: 0.43–1.49; respectively). Likewise, both light 
and heavy WP smokers had an insignificant statistical 
difference on the likelihood of circulating high TT 
levels (OR=0.92, 95% CI: 0.52–1.64; and OR=0.71, 
95% CI: 0.38–1.33; respectively). Similar findings 
were observed for other sex hormones as shown in 
Table 2.
DISCUSSION 
This is the first study exploring the relationship 
between WP smoking and serum testosterone 
values. There are numerous studies that have been 
conducted evaluating the impact of cigarette smoking 
on testosterone serum values7-9,16-20. Further, studies 
have shown that WP smoke contains diverse toxic 
compounds and highly concentrated nicotine 
and tobacco intoxicants compared to cigarettes2. 
Moreover, the carcinogenic PAH accumulated in one 
WP smoking session is 20 times greater than the PAH 
produced from a single cigarette21. Also, studies that 
explore the consequences of WP smoking on human 
health are scarce. Thus, due to the limited data on 
WP smoking and associated injurious effects, this 
study aimed to assess the relationship between WP 
smoking and testosterone levels in men in Qatar. Our 
results reveal no association between WP smoking 
and serum testosterone values, after adjusting for age 
and cigarette status. 
Although the effects of tobacco smoking on TT 
and FT values are controversial, the present study is 
supported by several other investigations19,20,22. For 
example, according to a population-based study of 890 
male participants of age 22–90 years, no significant 
effect of smoking on TT and FT values was detected, 
after adjusting for alcohol consumption, stroke, 
DM, and coronary heart disease as confounders18. 
Moreover, 255 men of age 30–70 years were studied 
in a cross-sectional investigation and no significant 
effect of smoking was found on TT and FT values, 
after adjusting for age, BMI, WHR, and prolactin17. 
Although these studies adjusted for non-confounding 
factors that should not be adjusted, such as BMI, 
WHR and prolactin, the findings of these studies are 
consistent with our results17,18. 
On the other hand, there are other investigations 
that report increases in the TT values associated with 
smoking7,8,16. In this regard, 1150 male patients were 
Table 2. Adjusted odds ratios and 95% confidence intervals of hormone levels divided into tertiles (Low and 
High, as defined) according to the level of WP smoking
Results were obtained by multiple logistic regression after adjustment for age and cigarette smoking. Abbreviations as in Table 1 footnote. 
WPS 
Status TT FT BioT SHBG
Low
(1.0–14.9)
High
(20.7–51.3)
Low
(0.04–0.3)
High
(0.4–1.4)
Low
(0.9–7.9)
High
(10.6–31)
Low
(2.5–26.0)
High
(38.0–118.0)
Light 0.83
(0.46–1.49)
0.92
(0.52–1.64)
0.84
(0.46–1.51)
0.79
(0.44–1.42)
0.80
(0.44–1.45)
0.73
(0.40–1.31)
0.75
(0.42–1.34)
0.76
(0.42–1.38)
Heavy 0.80
(0.43–1.49)
0.71
(0.38–1.33)
0.88
(0.47–1.64)
0.68
(0.36–1.27)
0.80
(0.42–1.50)
0.71
(0.38–1.34)
0.94
(0.50–1.77)
1.08
(0.57–2.03)
Tertiles
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analyzed in an infertility unit for sexual dysfunction 
and a significant increase in TT serum levels in 
smokers compared to non-smokers was noticed, after 
adjusting for age16. Nevertheless, the participants 
included in this study were referrals for sexual 
dysfunction, which introduces selection bias and 
decreases its generalizability. Therefore, the validity, 
as well as the suitable application to fit male smokers, 
is debatable. Moreover, in a cross-sectional study, 
3427 male participants were investigated to assess 
smoking on TT levels and an increase in TT levels 
in smokers compared to non-smokers was found, 
adjusted for age7. In contrast, studies suggest that 
smoking decreases TT levels; a case-control study 
involving 45 men, age 25–35 years, searched for an 
association between cigarette smoking and endocrine 
profile and found a decrease in TT values23. This study 
was also supported by another study24.
Furthermore, our results reveal that neither WP 
smoke nor cigarettes have an impact on the BioT in 
smokers compared to non-smokers. As such, our data 
agree with the limited studies published on this topic 
to date; English et al.25 and Halmenschlager et al.17 
both examined smoking on BioT levels and found 
no significant effect, after adjustment for age as a 
confounder. 
In general, most of the testosterone found in the 
human body is bound to SHBG. It is believed that 
65–80% of the TT is bound to SHBG26. Therefore, 
variations in SHBG could proportionally indicate 
changes in TT values. Thus, few studies suggest that 
smokers have a higher SHBG level compared to non-
smokers25,27. Here, we reveal that there is no significant 
difference in SHBG levels between WP smokers and 
non-WP smokers after adjusting for confounders, and 
this is supported by other investigations17,20,28.
Several studies in the literature report that 
WP smoking plays a mechanistic role in affecting 
testosterone levels23,29-33. These mechanisms are 
ambiguous; thus, theories so far are controversial, 
linking tobacco smoke with the outcome of 
testosterone values to several different pathways23,29-32. 
For instance, Kimura et al.29 anticipated that nicotine 
causes gamma-aminobutyric acid to be released which 
then inhibits gonadotropin-releasing hormone via the 
hypothalamus-pituitary pathway. In contrast, studies 
also proposed theories suggesting tobacco smoking 
could increase testosterone values31. For example, Wu 
et al.31, documented that the compensatory increase in 
luteinizing hormone (LH) primarily increases SHBG 
which would, therefore, increase total testosterone. 
However, our study does not agree with the above 
theories. Consequently, we propose that these effects 
do not induce a clinically significant alteration in 
testosterone values. 
Although the present study did not detect a 
significant effect on androgen values in WP smokers 
when compared to non-WP smokers, an impact of 
tobacco smoking on the reproductive system cannot 
be ruled out. There are numerous studies in the 
literature that suggest tobacco smoking decreases 
reproduction23,33. It is reported that nicotine and its 
substrate, cotinine, decreases the semen parameters 
and results in infertility34. Also, Gornig and Schirren35, 
demonstrated that smokers have a significant decrease 
in sperm motility and count. Their results were 
supported by several other studies23,36,37. These studies 
indicate that the decrease in semen parameters could 
be interpreted by the abundance of nicotine and lead, 
which are delivered through WP smoking. Thus, we 
believe that further studies are needed to confirm 
these data in other populations and to explore the 
effect of WP smoking on the human reproductive 
system as a whole. 
Limitations and strengths
There are several strengths and limitations in our 
study that need to be highlighted. First, the strengths 
include that our sample was selected randomly from 
QBB where subjects’ history of exposures were 
collected, and all tests were performed in a single 
laboratory. Second, the sample consisted of volunteers 
that were not referred by healthcare providers. Third, 
we avoided adjustment for non-confounding factors, 
which can introduce selection bias, by performing 
a DAG. On the other hand, the main limitation of 
our study was that we calculated FT and BioT using 
Vermeulen’s equation14 as they were not measured 
clinically by QBB. Although the calculated FT is a 
reliable index of the measured FT, it is recommended 
that testosterone values are measured using liquid 
chromatography-tandem mass spectroscopy as it is 
the gold standard, rather than calculating it, because 
of uncertainty38. Nevertheless, measuring BioT would 
be expensive and impractical. Another limitation 
was that we had only a single measurement for the 
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hormone values  used in the study. Also, the blood 
samples were collected within a wide time interval. 
Thus, changes in testosterone levels may be masked 
by circadian rhythm.
Finally, it is worth to mention that alcohol 
consumption and medications were not taken into 
account because of unavailable data. However, 
alcohol consumption is extremely rare in Qatar due 
to religious and social reasons and would not have 
affected the analysis. 
CONCLUSIONS
This study investigated for the first time the 
association between WP smoking and testosterone 
values. Our results demonstrate that there is no 
significant change in TT, FT, BioT and SHBG in WP 
smokers compared to non-WP smokers, after adjusting 
for age and cigarette smoking as confounders.
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